NewslettersCell Therapy News Phenotypic Insights into Genetic Risk Factors for Immune-Related Adverse Events in Cancer Immunotherapy By Noshin Noorjahan - November 4, 2024 0 1470 Utilizing publicly accessible genome-wide association study data, this investigation evaluated the impact of over 5000 exposure variables on susceptibility to irAEs using univariate Mendelian randomization. [Cancer Immunology Immunotherapy] Full Article